Chung Eui Suk, Lim Cheong, Lee Hae-Young, Choi Jin-Ho, Lee Jeong-Sang, Park Kay-Hyun
Department of Thoracic and Cardiovascular Surgery, Sanggye Paik Hospital, Inje University, Korea.
Korean J Thorac Cardiovasc Surg. 2011 Aug;44(4):273-8. doi: 10.5090/kjtcs.2011.44.4.273. Epub 2011 Aug 18.
Despite aggressive treatment, the mortality rate of cardiogenic shock with acute myocardial infarction (AMI) is high. We performed extracorporeal membrane oxygenation (ECMO) prior to coronary reperfusion, and evaluated the early clinical results and risk factors.
From May 2006 to November 2009, we reviewed the medical records of 20 patients in cardiogenic shock with AMI (mean age 67.7±11.7 yrs, M : F 14 : 6). After initially performing ECMO using the CAPIOX emergency bypass system (EBS®Terumo, Tokyo, Japan), patients underwent coronary reperfusion (coronary artery bypass grafting, 13; percutaneous coronary intervention, 7).
All patients were in a cardiogenic shock state, cardiopulmonary resuscitations (CPR) were performed for fourteen patients (mean CPR time 20.8±26.0 min). The mean time from vascular access to the initiation of ECMO was 17.2±9.4 min and mean support time was 3.8±4.0 days. Fourteen patients were able to be weaned from ECMO and ten patients were discharged (mean admission duration 50.1±31.6 days). Patients survived on average 476.6±374.6 days of follow-up. Longer CPR and support time, increased cardiac enzyme, lower ejection fraction, lower albumin, and major complications were the risk factors of mortality (p<0.05).
The early application of ECMO prior to coronary reperfusion and control of risk factors allowed for good clinical results in cardiogenic shock with AMI.
尽管进行了积极治疗,急性心肌梗死(AMI)所致心源性休克的死亡率仍很高。我们在冠状动脉再灌注之前实施了体外膜肺氧合(ECMO),并评估了早期临床结果和危险因素。
2006年5月至2009年11月,我们回顾了20例AMI所致心源性休克患者的病历(平均年龄67.7±11.7岁,男∶女为14∶6)。最初使用CAPIOX紧急旁路系统(EBS®Terumo,日本东京)进行ECMO后,患者接受了冠状动脉再灌注(冠状动脉旁路移植术13例;经皮冠状动脉介入治疗7例)。
所有患者均处于心源性休克状态,14例患者进行了心肺复苏(CPR)(平均CPR时间20.8±26.0分钟)。从血管通路建立到开始ECMO的平均时间为17.2±9.4分钟,平均支持时间为3.8±4.0天。14例患者能够脱离ECMO,10例患者出院(平均住院时间50.1±31.6天)。患者平均随访存活476.6±374.6天。较长的CPR时间和支持时间、心肌酶升高、射血分数降低、白蛋白降低以及主要并发症是死亡的危险因素(p<0.05)。
冠状动脉再灌注前早期应用ECMO并控制危险因素可使AMI所致心源性休克取得良好的临床效果。